These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12476046)

  • 41. Fucose supplementation in leukocyte adhesion deficiency type II.
    Etzioni A; Tonetti M
    Blood; 2000 Jun; 95(11):3641-3. PubMed ID: 10877554
    [No Abstract]   [Full Text] [Related]  

  • 42. Reconstitution, identification, and purification of the rat liver golgi membrane GDP-fucose transporter.
    Puglielli L; Hirschberg CB
    J Biol Chem; 1999 Dec; 274(50):35596-600. PubMed ID: 10585436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Secretory cell hyperplasia and defects in Notch activity in a mouse model of leukocyte adhesion deficiency type II.
    Waterhouse CC; Johnson S; Phillipson M; Zbytnuik L; Petri B; Kelly M; Lowe JB; Kubes P
    Gastroenterology; 2010 Mar; 138(3):1079-90.e1-5. PubMed ID: 19900444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The molecular basis of leukocyte recruitment and its deficiencies.
    Schmidt S; Moser M; Sperandio M
    Mol Immunol; 2013 Aug; 55(1):49-58. PubMed ID: 23253941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene therapy for leukocyte adhesion deficiency.
    Bauer TR; Hickstein DD
    Curr Opin Mol Ther; 2000 Aug; 2(4):383-8. PubMed ID: 11249768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defective intracellular activity of GDP-D-mannose-4,6-dehydratase in leukocyte adhesion deficiency type II syndrome.
    Sturla L; Etzioni A; Bisso A; Zanardi D; De Flora G; Silengo L; De Flora A; Tonetti M
    FEBS Lett; 1998 Jun; 429(3):274-8. PubMed ID: 9662431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leukocyte adhesion deficiency (LAD) II.
    Etzioni A; Phillips LM; Paulson JC; Harlan JM
    Ciba Found Symp; 1995; 189():51-8; discussion 58-62, 77-8. PubMed ID: 7587637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional expression of a human GDP-L-fucose transporter in Escherichia coli.
    Förster-Fromme K; Schneider S; Sprenger GA; Albermann C
    Biotechnol Lett; 2017 Feb; 39(2):219-226. PubMed ID: 27738779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Drosophila neurally altered carbohydrate mutant has a defective Golgi GDP-fucose transporter.
    Geisler C; Kotu V; Sharrow M; Rendić D; Pöltl G; Tiemeyer M; Wilson IB; Jarvis DL
    J Biol Chem; 2012 Aug; 287(35):29599-609. PubMed ID: 22745127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type I.
    Leon-Rico D; Aldea M; Sanchez-Baltasar R; Mesa-Nuñez C; Record J; Burns SO; Santilli G; Thrasher AJ; Bueren JA; Almarza E
    Hum Gene Ther; 2016 Sep; 27(9):668-78. PubMed ID: 27056660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fucose: biosynthesis and biological function in mammals.
    Becker DJ; Lowe JB
    Glycobiology; 2003 Jul; 13(7):41R-53R. PubMed ID: 12651883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of fucosylation in leukocyte adhesion deficiency II.
    Vestweber D; Lühn K; Marquardt T; Wild M
    Ernst Schering Res Found Workshop; 2004; (44):53-74. PubMed ID: 14579774
    [No Abstract]   [Full Text] [Related]  

  • 53. Lessons from rare maladies: leukocyte adhesion deficiency syndromes.
    Harris ES; Weyrich AS; Zimmerman GA
    Curr Opin Hematol; 2013 Jan; 20(1):16-25. PubMed ID: 23207660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leukocyte adhesion deficiencies: molecular basis, clinical findings, and therapeutic options.
    Etzioni A
    Adv Exp Med Biol; 2007; 601():51-60. PubMed ID: 17712991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful reconstitution of leukocyte adhesion defect after umbilical cord blood stem cell transplant.
    Chakraborty S; Gupta D; Thakral D; Bakhshi S; Kumar P; Kabra SK; Lodha R; Mitra DK
    Cent Eur J Immunol; 2020; 45(1):117-121. PubMed ID: 32425689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leukocyte adhesion deficiency (LAD) II: a new adhesion defect due to absence of sialyl Lewis X, the ligand for selectins.
    Etzioni A; Harlan JM; Pollack S; Phillips LM; Gershoni-Baruch R; Paulson JC
    Immunodeficiency; 1993; 4(1-4):307-8. PubMed ID: 7513226
    [No Abstract]   [Full Text] [Related]  

  • 57. Conversion of the severe to the moderate disease phenotype with donor leukocyte microchimerism in canine leukocyte adhesion deficiency.
    Gu YC; Bauer TR; Sokolic RA; Hai M; Tuschong LM; Burkholder T; Bacher J; Starost MF; Hickstein DD
    Bone Marrow Transplant; 2006 Mar; 37(6):607-14. PubMed ID: 16444276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukocyte adhesion deficiencies.
    van de Vijver E; van den Berg TK; Kuijpers TW
    Hematol Oncol Clin North Am; 2013 Feb; 27(1):101-16, viii. PubMed ID: 23351991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigen-specific immune responsiveness and lymphocyte recruitment in leukocyte adhesion deficiency type II.
    Kuijpers TW; Etzioni A; Pollack S; Pals ST
    Int Immunol; 1997 Apr; 9(4):607-13. PubMed ID: 9138022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leukocyte adhesion deficiency III: a group of integrin activation defects in hematopoietic lineage cells.
    Etzioni A; Alon R
    Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):485-90. PubMed ID: 15640688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.